[The advances in surgery for cirrhotic portal hypertension in China]

Area of Science:

• Gastroenterology and Hepatology
• Surgical Innovation

Background:

• Cirrhotic portal hypertension is a prevalent global health concern.
• Surgical treatments have faced challenges from non-surgical interventions over recent decades.

Purpose of the Study:

• To highlight the enduring significance of surgical interventions for cirrhotic portal hypertension.
• To emphasize the role of multidisciplinary team (MDT) collaboration in optimizing patient care.
• To introduce laparoscopic pericardial vascular devascularization as a minimally invasive surgical option.

Main Methods:

• Review of surgical and non-surgical treatment modalities for cirrhotic portal hypertension.
• Evaluation of the MDT approach in managing complex liver disease.
• Analysis of outcomes associated with laparoscopic pericardial vascular devascularization.

Main Results:

• Despite advancements, surgical treatment retains a unique and irreplaceable role in managing cirrhotic portal hypertension.
• Laparoscopic pericardial vascular devascularization demonstrates reduced injury, bleeding, and faster recovery compared to open procedures.
• The MDT model enhances the integration of various treatment strategies.

Conclusions:

• Surgical treatment, particularly minimally invasive approaches like laparoscopic pericardial vascular devascularization, remains crucial for cirrhotic portal hypertension.
• A standardized, individualized, and precise treatment strategy within an MDT framework maximizes clinical benefits for patients.
• Continued innovation in methods, technologies, and concepts under MDT care is essential for advancing treatment efficacy.